| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |